1183 related articles for article (PubMed ID: 8913503)
1. In vitro and in vivo antitumor activity of a novel nucleoside, 4'-thio-2'-deoxy-2'-methylidenecytidine.
Miura S; Tanaka M; Yoshimura Y; Satoh H; Sakata S; Machida H; Matsuda A; Sasaki T
Biol Pharm Bull; 1996 Oct; 19(10):1311-5. PubMed ID: 8913503
[TBL] [Abstract][Full Text] [Related]
2. High susceptibility of human cancer xenografts with higher levels of cytidine deaminase to a 2'-deoxycytidine antimetabolite, 2'-deoxy-2'-methylidenecytidine.
Miwa M; Eda H; Ura M; Ouchi KF; Keith DD; Foley LH; Ishitsuka H
Clin Cancer Res; 1998 Feb; 4(2):493-7. PubMed ID: 9516941
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of 2'-deoxy-2'-methylidenecytidine, a new 2'-deoxycytidine derivative.
Yamagami K; Fujii A; Arita M; Okumoto T; Sakata S; Matsuda A; Ueda T; Sasaki T
Cancer Res; 1991 May; 51(9):2319-23. PubMed ID: 2015596
[TBL] [Abstract][Full Text] [Related]
4. The antiproliferative activity of DMDC is modulated by inhibition of cytidine deaminase.
Eda H; Ura M; F-Ouchi K; Tanaka Y; Miwa M; Ishitsuka H
Cancer Res; 1998 Mar; 58(6):1165-9. PubMed ID: 9515801
[TBL] [Abstract][Full Text] [Related]
5. Nucleosides and nucleotides. 97. Synthesis of new broad spectrum antineoplastic nucleosides, 2'-deoxy-2'-methylidenecytidine (DMDC) and its derivatives.
Matsuda A; Takenuki K; Tanaka M; Sasaki T; Ueda T
J Med Chem; 1991 Feb; 34(2):812-9. PubMed ID: 1995905
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of a novel orally effective nucleoside, 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl)cytosine.
Miura S; Yoshimura Y; Endo M; Machida H; Matsuda A; Tanaka M; Sasaki T
Cancer Lett; 1998 Jul; 129(1):103-10. PubMed ID: 9714341
[TBL] [Abstract][Full Text] [Related]
7. The relationship between the antitumor activity and the ribonucleotide reductase inhibitory activity of (E)-2'-deoxy-2'-(fluoromethylene) cytidine, MDL 101,731.
Kanazawa J; Takahashi T; Akinaga S; Tamaoki T; Okabe M
Anticancer Drugs; 1998 Aug; 9(7):653-7. PubMed ID: 9773810
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of 4'-thio-beta-D-arabinofuranosylcytosine in CEM cells.
Parker WB; Shaddix SC; Rose LM; Waud WR; Shewach DS; Tiwari KN; Secrist JA
Biochem Pharmacol; 2000 Dec; 60(12):1925-32. PubMed ID: 11108809
[TBL] [Abstract][Full Text] [Related]
9. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
Niitsu N; Ishii Y; Matsuda A; Honma Y
Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl)cytosine with gemcitabine in its antitumor activity.
Miura S; Yoshimura Y; Endo M; Satoh H; Machida H; Sasaki T
Cancer Lett; 1999 Oct; 144(2):177-82. PubMed ID: 10529018
[TBL] [Abstract][Full Text] [Related]
11. Novel DNA methyltransferase-1 (DNMT1) depleting anticancer nucleosides, 4'-thio-2'-deoxycytidine and 5-aza-4'-thio-2'-deoxycytidine.
Thottassery JV; Sambandam V; Allan PW; Maddry JA; Maxuitenko YY; Tiwari K; Hollingshead M; Parker WB
Cancer Chemother Pharmacol; 2014 Aug; 74(2):291-302. PubMed ID: 24908436
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anticancer and antiviral activities of various 2'- and 3'-methylidene-substituted nucleoside analogues and crystal structure of 2'-deoxy-2'-methylidenecytidine hydrochloride.
Lin TS; Luo MZ; Liu MC; Clarke-Katzenburg RH; Cheng YC; Prusoff WH; Mancini WR; Birnbaum GI; Gabe EJ; Giziewicz J
J Med Chem; 1991 Aug; 34(8):2607-15. PubMed ID: 1652024
[TBL] [Abstract][Full Text] [Related]
13. Nucleosides and nucleotides. 176. 2'-Deoxy-2'-hydroxylaminocytidine: a new antitumor nucleoside that inhibits DNA synthesis although it has a ribonucleoside structure.
Ogawa A; Shuto S; Inanami O; Kuwabara M; Tanaka M; Sasaki T; Matsuda A
Bioorg Med Chem Lett; 1998 Jul; 8(14):1913-8. PubMed ID: 9873458
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics of 2'-deoxy-2'-methylidenecytidine (DMDC), a deoxycytidine analogue antineoplastic agent.
Brindley CJ; Morrison R; Gordon RJ; Devlin AJ; van der Gaast A; Verweij L; Funaki T
Clin Pharmacokinet; 2000 Jun; 38(6):475-91. PubMed ID: 10885585
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of 4'-Thionucleosides as Antitumor and Antiviral Agents.
Yoshimura Y; Saito Y; Natori Y; Wakamatsu H
Chem Pharm Bull (Tokyo); 2018; 66(2):139-146. PubMed ID: 29386464
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of a novel nucleoside, 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosylcytosine (CNDAC) against murine and human tumors.
Tanaka M; Matsuda A; Terao T; Sasaki T
Cancer Lett; 1992 May; 64(1):67-74. PubMed ID: 1596880
[TBL] [Abstract][Full Text] [Related]
17. Nucleosides and nucleotides. 180. Synthesis and antitumor activity of nucleosides that have a hydroxylamino group instead of a hydroxyl group at the 2'- or 3'-position of the sugar moiety.
Ogawa A; Tanaka M; Sasaki T; Matsuda A
J Med Chem; 1998 Dec; 41(25):5094-107. PubMed ID: 9836625
[TBL] [Abstract][Full Text] [Related]
18. Phase I trial of oral 2'-deoxy-2'-methylidenecytidine: on a daily x 14-day schedule.
Masuda N; Matsui K; Yamamoto N; Nogami T; Nakagawa K; Negoro S; Takeda K; Takifuji N; Yamada M; Kudoh S; Okuda T; Nemoto S; Ogawa K; Myobudani H; Nihira S; Fukuoka M
Clin Cancer Res; 2000 Jun; 6(6):2288-94. PubMed ID: 10873079
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and antineoplastic activity of 2'-deoxy-2'-methylidenecytidine.
Takenuki K; Matsuda A; Ueda T; Sasaki T; Fujii A; Yamagami K
J Med Chem; 1988 Jun; 31(6):1063-4. PubMed ID: 3373480
[No Abstract] [Full Text] [Related]
20. A novel synthesis of antineoplastic 4'-thionucleosides using D-glucose as a chiral synthon.
Yoshimura Y; Satoh H; Watanabe M; Sakata S; Miura S; Tanaka M; Sasaki T; Matsuda A
Nucleic Acids Symp Ser; 1995; (34):161-2. PubMed ID: 8841602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
